Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06384586
Other study ID # CD J8855
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 17, 2022
Est. completion date December 22, 2022

Study information

Verified date April 2024
Source The Water Street Collective
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a single center, randomized, double blind, placebo-controlled, crossover study to determine the acute effect of a developmental dietary supplement liquid shot product on cognitive task performance and perceived effect measures related to mood and mental energy. The study will be conducted in healthy participants.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date December 22, 2022
Est. primary completion date December 22, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: MAIN INCLUSION CRITERIA: 1. Participants must be willing to abstain from alcohol, caffeine and exercise starting from the night before each session. 2. Participants that, on average, consume between 200 and 500 mgs of caffeine per day. 3. Participants that are in good physical and mental health. 4. Participants that are willing to come in-person and be within less than 6 feet of study staff for a short period of time. 5. Participants that are able to provide written informed consent to participate in the study and will have agreed to abide by the study restrictions, requirements and protocol. 6. Participants must, in the opinion of the Principal Investigator (or designee), demonstrate the ability to comprehend the informed consent form (ICF), be able to communicate well with the Investigator, understand and comply with the requirements of the study, and be judged suitable for the study. 7. Participants must be available to complete the study. 8. Participants must be willing to consume a normal-sized meal (participant responsible for obtaining or preparing the meal) at least one hour prior to the start of the study session and then fast from food and beverage consumption (except water), for one hour prior to each research session. Exclusion Criteria: 1. Participants that are not US citizens or are residents of California. 2. Participants that have a medical condition, including but not limited to heartbeat/rhythm irregularities, past heart attacks, been diagnosed with heart disease, seizure disorder, liver condition, blood clotting disorder, endocrine-related medical diagnosis (such as diabetes, thyroid, etc.), serious health condition (i.e. cancer, etc.), blindness, gastrointestinal sensitivity/condition, depression, insomnia, anxiety, hypertension, PKU (Phenylketonuria), Celiac disease or deafness. If a participant has any other medical condition or metabolic condition that prevents them from being able to fast for one hour, they will not be allowed to participate in this study. 3. Participants that have a loss of taste or smell or are currently suffering from a virus/infection that affects their ability to taste or smell. 4. Participants that are left-handed, have dyscalculia, have paralysis which effects the upper body, or are color-blind, as this could impact their ability to complete the cognitive tasks. 5. Participants that use recreational drugs or that are currently taking medication (except for a contraceptive), or other drugs including non-prescription (over the counter) medications, pseudoephedrine, non-prescription painkillers such as paracetamol (acetaminophen), ibuprofen or aspirin. 6. Participants that are taking green tea extract or any diet medications, appetite suppressors or supplements (including, but not limited to, fitness supplements containing green tea extract and caffeine, and workout supplements that are intended to assist with weight loss (such as phentermine)). 7. Participants that are pregnant, breastfeeding (or pumping/expressing) or intend to become pregnant in the next six months.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Placebo shot
60ml shot served in an amber bottle and consumed after 40 minutes of baseline assessments
Functional energy shot
60ml shot served in an amber bottle and consumed after 40 minutes of baseline assessments

Locations

Country Name City State
United States Schlesinger Group New Jersey Iselin New Jersey

Sponsors (3)

Lead Sponsor Collaborator
The Water Street Collective British American Tobacco (Investments) Limited, HCD Research

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mental energy via Cognitive Demand Battery (CDB) Performance Index; for the functional energy shot versus placebo shot. CDB performance index score is a comprised averaged Z scores for the principal performance measure for each of the three tasks: Rapid Visual Information Processing (RVIP) % accuracy, Serial 3s total number correct, Serial 7s total number correct. A higher score signifies performance improvement. Objective tests within Computerised Mental Performance Assessment framework tasks (COMPASS) Change from baseline to 120 min post- shot consumption
Secondary Mental energy via Cognitive Demand Battery (CDB) Accuracy score for the functional energy shot versus placebo shot. CDB accuracy score is a comprised averaged Z scores for the principal measures of accuracy of performance for the three tasks: Rapid Visual Information Processing (RVIP) % accuracy; Serial 3s % errors; Serial 7s % errors (the latter two were inverted so that a higher Z score related to better accuracy). A higher score signifies performance improvement.
Objective tests within Computerised Mental Performance Assessment framework tasks (COMPASS)
Change from baseline to 120 min post- shot consumption
Secondary Change in performance on Corsi blocks task for functional energy shot versus placebo Objective tests within Computerised Mental Performance Assessment framework tasks (COMPASS) Change from baseline to 120 min post- shot consumption
Secondary Change in performance on Rapid Visual Information Processing (RVIP) for functional energy shot versus placebo Objective tests within Computerised Mental Performance Assessment framework tasks (COMPASS) Change from baseline to 120 min post- shot consumption
Secondary Change in performance on Numeric working memory for functional energy shot versus placebo Objective tests within Computerised Mental Performance Assessment framework tasks (COMPASS) Change from baseline to 120 min post- shot consumption
Secondary Change in performance on Serial subtraction task for functional energy shot versus placebo Objective tests within Computerised Mental Performance Assessment framework tasks (COMPASS) Change from baseline to 120 min post- shot consumption
Secondary Change in Mood via Visual Analogue Scales (VAS) during Cognitive Demand Battery (CDB), for functional energy shot versus placebo 0-100 mm subjective rating scale from none to strongest feelings, within Computerised Mental Performance Assessment framework tasks (COMPASS) for mental fatigue, alert, sociable, simulated, jittery, physical energy. The minimum score is 0 and the maximum score is 100. Change from baseline to 120 min post- shot consumption
Secondary Change in physiological state via Profile Of Mood States (POMS) during Cognitive Demand Battery (CDB), for functional energy shot versus placebo a 37-item inventory, the individual item scores of which are collapsed into six dimensions of mood: anger/hostility, confusion/bewilderment, depression/dejection, fatigue/inertia, tension/anxiety, and vigour/activity. Change from baseline to 120 min post- shot consumption
See also
  Status Clinical Trial Phase
Withdrawn NCT04540523 - Home-Based Exergaming Intervention N/A
Suspended NCT01212029 - Testing and Calibration of Non-Invasive Optical Imaging Technology for Functional Brain Imaging N/A
Enrolling by invitation NCT05273970 - Electrochemical and Electrophysiological Study N/A
Recruiting NCT05227352 - Bio-Experiential Spaces for Mental Health in Healthworkers N/A
Completed NCT02671149 - The Effect of Small Changes in Hydration on Cognition N/A
Completed NCT01333306 - Enhancing Cognitive Training Using tDCS Phase 1
Recruiting NCT05542199 - Nutrition for Brain and Body Health (BB-Health) Feasibility Trial N/A
Recruiting NCT06331286 - The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity N/A
Recruiting NCT06254638 - Effectiveness of a Multicomponent Intervention to Promote Physical Activity Levels During the School Day (MOVESCHOOL) N/A
Completed NCT05998096 - A Randomized Study to Examine the Ability of a Caffeine-Based Energy Drink to Impact Energy Expenditure, Fat Oxidation, Reaction Time, and Other Perceptual Indicators N/A
Withdrawn NCT03224559 - Applying Neuromodulation to Accelerate Training Effects
Completed NCT03129048 - Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults N/A
Recruiting NCT05394363 - Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Suspended NCT05107947 - Light in Frail Elderly - the Effect of a Dynamic Light for Sleep and Circadian Rhythm N/A
Recruiting NCT05372172 - Tennessee Alzheimer's Project
Recruiting NCT05132517 - Magnesium and Cognition After Stroke
Recruiting NCT05992571 - Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity N/A
Recruiting NCT06097182 - Postbiotic Intervention for Acute Stress Management N/A
Completed NCT01223404 - Nicotinic Modulation of the Default Network N/A
Completed NCT00687102 - Cognition in the Study of Tamoxifen and Raloxifene Phase 3